Managing Patent Foramen Ovale (PFO) in Adults With Cryptogenic Stroke and Lymphoma: A Multidisciplinary Perspective

被引：0

作者：

Khalid, Noman ^{[1
]}

Abdullah, Muhammad ^{[2
]}

Ozgur, Sacide S. ^{[1
]}

Elkattawy, Sherif ^{[3
]}

Shamoon, Fayez ^{[3
]}

机构：

[1] St Josephs Reg Med Ctr, Internal Med, Paterson, NJ 07530 USA

[2] Shaikh Zayed Fed Postgrad Med Inst, Shaikh Khalifa Bin Zayed Al Nahyan Med & Dent Coll, Publ Hlth & Community Med, Shaikh Zayed Med Complex, Lahore, Pakistan

[3] St Josephs Reg Med Ctr, Cardiol, Paterson, NJ USA

来源：

CUREUS JOURNAL OF MEDICAL SCIENCE | 2023年 / 15卷 / 06期

关键词：

lymphoma; bubble study; paradoxical emboli; cryptogenic stroke; patent foramen ovale; CLOSURE;

D O I：

10.7759/cureus.40316

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Cryptogenic strokes are strokes with no clear underlying cause. Patent foramen ovale (PFO) is believed to be one of the causes of cryptogenic strokes. To manage such cases, closing the PFO is usually considered an option. We report a case of a middle-aged male with lymphoma who presented with an altered mental status due to a stroke, which, on investigation, was found to be due to an underlying PFO. This report explores the factors that must be considered when making the decision to close the PFO and emphasizes the vital role of a multi-disciplinary team in determining the best course of action for patients with cryptogenic strokes.

引用

页数：4

共 9 条

[1] Updated meta-analysis of closure of patent foramen ovale versus medical therapy after cryptogenic stroke
Bin Nasir, Usama
Qureshi, Wacias T.
Jogu, Humanatha
Wolfe, Elizabeth
Dutta, Abhishek
Majeed, Chaudhry Nasir
Tan, Walter A.
[J]. CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2019, 20 (03) : 187 - 193
[2] Hampton T, 2022, STATPEARLS
[3] Patent foramen ovale closure to prevent secondary neurologic events
Jasper, Rosie
Blankenship, James C.
[J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2017, 44 : 1 - 11
[4] Kavinsky Clifford J, 2022, J Soc Cardiovasc Angiogr Interv, V1, P100039, DOI 10.1016/j.jscai.2022.100039
[5] Heterogeneity of Treatment Effects in an Analysis of Pooled Individual Patient Data From Randomized Trials of Device Closure of Patent Foramen Ovale After Stroke
Kent, David M.
Saver, Jeffrey L.
Kasner, Scott E.
Nelson, Jason
Carroll, John D.
Chatellier, Gilles
Derumeaux, Genevieve
Furlan, Anthony J.
Herrmann, Howard C.
Juni, Peter
Kim, Jong S.
Koethe, Benjamin
Lee, Pil Hyung
Lefebvre, Benedicte
Mattle, Heinrich P.
Meier, Bernhard
Reisman, Mark
Smalling, Richard W.
Soendergaard, Lars
Song, Jae-Kwan
Mas, Jean-Louis
Thaler, David E.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (22): : 2277 - 2286
[6] Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline
Kuijpers, Ton
Spencer, Frederick A.
Siemieniuk, Reed A. C.
Vandvik, Per O.
Otto, Catherine M.
Lytvyn, Lyubov
Mir, Hassan
Jin, Albert Y.
Manja, Veena
Karthikeyan, Ganesan
Hoendermis, Elke
Martin, Janet
Carballo, Sebastian
O'Donnell, Martin
Vartdal, Trond
Baxter, Christine
Patrick-Lake, Bray
Scott, Joanie
Agoritsas, Thomas
Guyatt, Gordon
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2018, 362
[7] Advances in the management of cardioembolic stroke associated with patent foramen ovale
Mac Grory, Brian
Ohman, E. Magnus
Feng, Wuwei
Xian, Ying
Yaghi, Shadi
Kamel, Hooman
Reznik, Michael E.
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2022, 376
[8] Patent foramen ovale and cryptogenic stroke
Nakanishi, Koki
Yoshiyama, Minoru
Homma, Shunichi
[J]. TRENDS IN CARDIOVASCULAR MEDICINE, 2017, 27 (08) : 575 - 581
[9] Antithrombotic and Thrombolytic Therapy for Valvular Disease Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Whitlock, Richard P.
Sun, Jack C.
Fremes, Stephen E.
Rubens, Fraser D.
Teoh, Kevin H.
[J]. CHEST, 2012, 141 (02) : E576S - E600S

← 1 →